Tag: respiratory syncytial virus (RSV) vaccine candidate
Pfizer starts four phase 3 clinical trials for investigational vaccines
Pfizer announced the initiation of four phase 3 clinical trials within its current pipeline of investigational vaccines. First subjects recently administered immunizations in two...